Phytochemicals induce breast cancer resistance protein in caco-2 Cells and enhance the transport of nenzo[a]pyrene-3-sulfate

Toxicological Sciences

Volumn 96, Issue 2, 2007, Pages 227-236

  Ebert, Bettina ^a   Seidel, Albrecht ^b   Lampen, Alfonso ^c  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b Prof Dr Gernot Grimmer Foundation   (Germany)

^c FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

Author keywords

BCRP; Benzo a pyrene; Caco 2 cells; Dibenzoylmethane; Phytochemicals; Qercetin

Indexed keywords

3 INDOLEMETHANOL; AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE DERIVATIVE; BREAST CANCER RESISTANCE PROTEIN; CARCINOGEN; CHRYSIN; CURCUMIN; DIBENZOYLMETHANE DERIVATIVE; EPICATECHIN; FLAVONE; GENISTEIN; MALEIC ACID DIETHYL ESTER; MESSENGER RNA; PLANT MEDICINAL PRODUCT; PROTEASOME; QUERCETIN; RESVERATROL; SILIBININ; SULFORAPHANE; TERT BUTYLHYDROQUINONE;

ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CELL STRAIN CACO 2; CELL STRAIN MCF 7; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEGRADATION KINETICS; DETOXIFICATION; DRUG STRUCTURE; FOOD COMPOSITION; HUMAN; HUMAN CELL; HYPOTHESIS; INHIBITION KINETICS; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; TEA; TRANSPORT KINETICS; WILD TYPE;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; ATP-BINDING CASSETTE TRANSPORTERS; BENZO(A)PYRENE; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CATECHIN; CELL LINE, TUMOR; CHALCONES; FLAVONOIDS; GENE EXPRESSION; HUMANS; HYDROQUINONES; INDOLES; MALEATES; MOLECULAR STRUCTURE; NEOPLASM PROTEINS; PLANT EXTRACTS; QUERCETIN; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; SILYMARIN; STILBENES; THIOCYANATES; TRANSFECTION;

EID: 33947233105     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfl147     Document Type: Article

References (48)

1. Allen, J. D., Brinkhuis, R. F., Wijnholds, J., and Schinkel, A. H. (1999). The mouse Bcrp1/Mxr/Abcp gene: Amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin. Cancer Res. 59, 4237-4241.
2. Ashida, H., Fukuda, I., Yamashita, T., and Kanazawa, K. (2000). Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin. FEBS Lett. 476, 213-217.
3. Banning, A., Deubel, S., Kluth, D., Zhou, Z., and Brigelius-Flohé, R. (2005). The GI-GPx gene is a target for Nrf2. Mol. Cell Biol. 25, 4914-4923.
4. Bonnesen, C., Eggleston, I. M., and Hayes, J. D. (2001). Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res. 61, 6120-6130.
5. Buesen, R., Mock, M., Seidel, A., Jacob, J., and Lampen, A. (2002). Interaction between metabolism and transport of benzo[a]pyrene and its metabolites in enterocytes. Toxicol. Appl. Pharmacol. 183, 168-178.
6. Ciolino, H. P., Dankwah, M., and Yeh, G. C. (2002). Resistance of MCF-7 cells to dimethylbenz[a]apoptosis is due to reduced CYP1A1 expression. Int. J. Oncol. 21, 385-391.
7. Ciolino, H. P., Daschner, P. J., and Yeh, G. C. (1998). Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res. 58, 5707-5712.
8. Ciolino, H. P., Daschner, P. J., and Yeh, G. C. (1999). Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affects CYP1A1 transcription differentially. Biochem. J. 340, 715-722.
9. Denison, M. S., and Nagy, S. R. (2003). Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43, 309-334.
10. Di Pietro, A., Conseil, G., Perez-Victoria, J.M., Dayan,G., Baubichon-Cortay, H., Trompier,D., Steinfels, E., Jault, J.M., de Wet, H., Maitrejean, M., et al. (2002). Modulation by flavonoids of cell multidrug resistance mediated by Pglycoprotein and related ABC transporters. Cell Mol. Life Sci. 59, 307-322.
11. Dolwick, K. M., Schmidt, J. V., Carver, L. A., Swanson, H. I., and Bradfield, C. A. (1993). Cloning and expression of a human Ah receptor cDNA. Mol. Pharmacol. 44, 911-917.
12. Ebert, B., Seidel, A., and Lampen, A. (2005). Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis 26, 1754-1763.
13. Ee, P. L., Kamalakaran, S., Tonetti, D., He, X., Ross, D. D., and Beck, W. T. (2004). Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res. 64, 1247-1251.
14. Formica, J. V., and Regelson, W. (1995). Review of the biology of quercetin and related bioflavonoids. Food Chem. Toxicol. 33, 1061-1080.
15. Gasiewicz, T. A., Kende, A. S., Rucci, G., Whitney, B., and Willey, J. J. (1996). Analysis of structural requirements for Ah receptor antagonist activity: Ellipticines, flavones, and related compounds. Biochem. Pharmacol. 52, 1787-1803.
16. Gehm, B. D., McAndrews, J. M., Chien, P.-Y., and Jameson, J. L. (1997). Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 94, 14138-14143.
17. Gharavi, N., and El-Kadi, A. O. (2005). tert-Butylhydroquinone is a novel aryl hydrocarbon receptor ligand. Drug Metab. Dispos. 33, 365-372.
18. Greenwald, P., Clifford, C. K., and Milner, J. A. (2001). Diet and cancer prevention. Eur. J. Cancer 37, 948-965.
19. Haimeur, A., Conseil, G., Deeley, R. G., and Cole, S. P. C. (2004). The MRP-related and BCRP/ABCG2 multidrug resistance proteins: Biology, substrate specificity and regulation. Curr. Drug Metab. 5, 21-53.
20. Han, Y., and Sugiyama, Y. (2006). Expression and regulation of breast cancer resistance protein and multidrug resistance associated protein 2 in BALB/c mice. Biol. Pharm. Bull. 29, 1032-1035.
21. Hankinson, O. (1995). The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35, 307-340.
22. Havsteen, B. H. (2002). The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 96, 67-202.
23. Jonker, J.W., Buitelaar, M., Wagenaar, E., Van Der Valk, M. A., Scheffer, G. L., Scheper, R. J., Plosch, T., Kuipers, F., Elferink, R. P., Rosing, H., et al. (2002). The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. U.S.A. 99, 15649-15654.
24. Kohno, H., Tanaka, T., Kawabata, K., Hirose, Y., Sugie, S., Tsuda, H., and Mori, H. (2002). Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats. Int. J. Cancer 101, 461-468.
25. Krishnamurthy, P., and Schuetz, J. D. (2006). Role of ABCG2/BCRP in biology and medicine. Annu. Rev. Pharmacol. Toxicol. 46, 381-410.
26. Leslie, E. M., Mao, Q., Oleschuk, C. J., Deeley, R. G., and Cole, S. P. (2001). Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATPase activities by interaction with dietary flavonoids. Mol. Pharmacol. 59, 1171-1180.
27. Ma, Q., and Baldwin, K. T. (1999). 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway. J. Biol. Chem. 275, 8432-8438.
28. Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C., Schinkel, A. H., van De Vijver, M. J., Scheper, R. J., and Schellens, J. H. (2001). Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 61, 3458-3464.
29. Mao, Q., and Unadkat, J. D. (2005). Role of breast cancer resistance protein (ABCG2) in drug transport. AAPS J. 7, E118-E131.
30. Martinez, M. E. (2005). Primary prevention of colorectal cancer: Lifestyle, nutrition, exercise. Recent Results Cancer Res. 166, 177-211.
31. Moskaug, J. O., Carlsen, H., Myhrstad, M., and Blomhoff, R. (2004). Molecular imaging of the biological effects of quercetin and quercetin-rich foods. Mech. Ageing. Dev. 125, 315-324.
32. Nguyen, T., Sherratt, P. J., and Pickett, C. B. (2003). Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu. Rev. Pharmacol. Toxicol. 43, 233-260.
33. Pavek, P., Merino, G., Wagenaar, E., Bolscher, E., Novotna, M., Jonker, J. V., and Schinkel, A. H. (2005). Human breast cancer resistance protein (BCRP/ABCG2): Interactions with steroid drugs, hormones, the dietary carcinogen PhIP, and transport of cimetidine. J. Pharmacol. Exp. Ther. 312, 144-152.
34. Poland, A., Glover, E., and Taylor, B. A. (1987). The murine Ah locus: A new allele and mapping to chromosome 12. Mol. Pharmacol. 32, 471-478.
35. Rushmore, T. H., Morton, M. R., and Pickett, C. B. (1991). The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 266, 11632-11639.
36. Schrickx, J., Lektarau, Y., and Fink-Gremmels, J. (2006). Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cells. Arch. Toxicol. 80, 243-249.
37. Shimada, T., Yamazaki, H., Foroozesh, M., Hopkins, N. E., Alworth, W. L., and Guengerich, F. P. (1998). Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1. Chem. Res. Toxicol. 11, 1048-1056.
38. Signorelli, P., and Ghidoni, R. (2005). Resveratrol as an anticancer nutrient: Molecular basis, open questions and promises. J. Nutr. Biochem. 16, 449-466.
39. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985). Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85.
40. Steinmetz, K. A., and Potter, J. D. (1991). Vegetables, fruit and cancer. II. Mechanisms. Cancer Causes Control 2, 427-442.
41. Terry, P., Terry, J. B., and Wolk, A. (2001). Fruit and vegetable consumption in the prevention of cancer: An update. J. Intern. Med. 250, 280-290.
42. van Herwaarden, A. E., Wagenaar, E., Karnekamp, B., Merino, G., Jonker, J. W., and Schinkel, A. H. (2006). Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk. Carcinogenesis 27, 123-130.
43. Wargovich, M. J. (1997). Experimental evidence for cancer preventive elements in food. Cancer Lett. 114, 11-17.
44. Wattenberg, L. W. (1992). Inhibition of carcinogenesis by minor dietary constituents. Cancer Res. 52, 2085s-2091s.
45. Xia, C. Q., Liu, N., Yang, D., Miwa, G., and Gan, L. S. (2005). Expression, localization, and functional characteristics of breast cancer resistance protein in Caco-2 cells. Drug Metab. Dispos. 33, 637-643.
46. Yang, C. S., Landau, J. M., Huang, M.-T., and Newmark, H. L. (2001). Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr. 21, 381-406.
47. Zhang, S., and Morris, M. E. (2003). Effects of the flavonoids biochanin A, morin, phloretin and silymarin on P-glycoprotein-mediated transport. J. Exp. Pharmacol. Ther. 304, 1258-1267.
48. Zhang, S., Qin, C., and Safe, S. (2003). Flavonoids as aryl hydrocarbon receptor agonists/antagonists: Effects of structure and cell context. Environ. Health Perspect. 111, 1877-1881.